Changfeng Miao
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Integrative Single-Cell and Bulk Transcriptome Analysis Reveals Molecular Mechanisms, Prognostic Signatures, and Therapeutic Response in Glioma.
Journal: The Journal of craniofacial surgery
Published: June 02, 2026
The role of the WD40-repeat protein family in cancer.
Journal: Molecular cancer
Published: March 12, 2026
Knowledge Mapping of Exosomes in Glioblastoma: A Bibliometric Analysis From 2006 to 2025.
Journal: The Journal of craniofacial surgery
Published: February 21, 2026
ANXA5: A Multi-Omics-Derived, UPR-Associated Dual-Function Biomarker for Prognosis and Immunotherapy Response Prediction in Glioma.
Journal: BioFactors (Oxford, England)
Published: January 16, 2026
Establishment of Vasculogenic Mimicry-Correlated Model to Predict Prognosis and Therapeutic Efficacy in Patients With Glioblastoma.
Journal: The Journal of craniofacial surgery
Published: January 10, 2026
Lactylation in cancer: molecular mechanisms and advances in clinical study.
Journal: Molecular cancer
Published: November 04, 2025
COL8A1 as a pro-inflammatory mediator bridges immune evasion and therapy resistance in glioma.
Journal: Frontiers in immunology
Published: October 17, 2025
Single-Cell and Bulk Transcriptomic Integration Reveals a Stemness-Related Astrocyte Subpopulation for Prognostic Risk Stratification in Glioblastoma.
Journal: Current medicinal chemistry
Published: October 09, 2025
Exosome-based liquid biopsy for rare and complex diseases.
Journal: International journal of surgery (London, England)
Published: August 22, 2025
Exosomes: innovative biomarkers leading the charge in non-invasive cancer diagnostics.
Journal: Theranostics
Published: March 12, 2025
Deciphering the Role of SLFN12: A Novel Biomarker for Predicting Immunotherapy Outcomes in Glioma Patients Through Artificial Intelligence.
Journal: Journal of cellular and molecular medicine
Published: November 13, 2024
Olfactory mucosa-mesenchymal stem cells with overexpressed Nrf2 modulate angiogenesis and exert anti-inflammation effect in an in vitro traumatic brain injury model.
Journal: European journal of medical research
Published: November 11, 2024
Last Updated: 09/26/2026